Liquidia Corporation (LQDA) vs Pharvaris N.V. (PHVS)
A side-by-side comparison of Liquidia Corporation and Pharvaris N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LQDA
Liquidia Corporation
$26.22HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PHVS
Pharvaris N.V.
$30.75HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — LQDA vs PHVS
growth of $100 · dividends reinvested · last 6yLQDA +735.0% (+42.4%/yr)PHVS +5.1% (+0.8%/yr)LQDA compounded faster over this window
Log scale — wide-divergence pair
LQDA PHVS
LQDA vs PHVS: by the numbers
- •LQDA is the larger company ($2.33B vs $2.15B market cap).
- •LQDA is profitable (30.74% net margin) while PHVS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | LQDA | PHVS |
|---|---|---|
| P/E ratio | 19.15 | N/A |
| Forward P/E | 10.55 | N/A |
| P/S ratio | 5.17 | N/A |
| P/B ratio | 11.95 | 6.25 |
| EV / EBITDA | 12.78 | N/A |
| FCF yield | 2.60% | N/A |
Profitability
| Metric | LQDA | PHVS |
|---|---|---|
| Gross margin | 92.48% | 0.00% |
| Operating margin | -32.45% | 0.00% |
| Net margin | 30.74% | 0.00% |
| ROE | 71.04% | -57.96% |
| ROIC | 46.99% | -61.74% |
Growth (annualized)
| Metric | LQDA | PHVS |
|---|---|---|
| Revenue CAGR (5Y) | 128.77% | N/A |
| Total return CAGR (5Y) | 59.01% | 11.45% |
Frequently asked
- Is LQDA or PHVS more profitable?
- LQDA runs the higher net margin — LQDA at 30.74% versus PHVS at 0.00%.
- How have LQDA and PHVS total returns compared?
- Over the past 5 years, LQDA delivered 59.01% and PHVS delivered 11.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Liquidia P/E ratioLiquidia ROEPharvaris ROELiquidia operating marginPharvaris operating marginLiquidia revenue growthPharvaris revenue growthLiquidia free cash flowPharvaris free cash flow
Liquidia & Pharvaris appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.